Table 4. Risk Estimates (95% Confidence Intervals) for CHD Mortality in Women at the Index Age of 35.
TC | Category: SBP/DBP, mmHg | Intermediate-Term Risk, % |
|||||
---|---|---|---|---|---|---|---|
10-Year | 20-Year | 30-Year | 40-Year | 50-Year | LTR, % | ||
< 5.7 | |||||||
(< 220 mg/dL) | Normal: | 0.00 | 0.00 | 0.05 | 0.14 | 0.96 | 1.83 |
< 130/< 80 | (0.00–0.00) | (0.00–0.00) | (0.00–0.09) | (0.04–0.23) | (0.45–1.37) | (0.94–2.50) | |
High BP: | 0.00 | 0.00 | 0.04 | 0.42 | 1.40 | 3.02 | |
130–139/80–89 | (0.00–0.00) | (0.00–0.00) | (0.00–0.09) | (0.21–0.60) | (0.85–1.86) | (1.91–3.88) | |
G1 hypertension: | 0.00 | 0.06 | 0.06 | 0.34 | 1.63 | 3.55 | |
140–159/90–99 | (0.00–0.00) | (0.00–0.18) | (0.00–0.18) | (0.13–0.54) | (1.03–2.12) | (2.48–4.36) | |
G2–3 hypertension: | 0.00 | 0.20 | 0.26 | 0.68 | 1.96 | 3.78 | |
≥ 160/≥ 100 | (0.00–0.00) | (0.00–0.59) | (0.00–0.67) | (0.15–1.17) | (1.06–2.71) | (2.34–4.82) | |
≥ 5.7 | |||||||
(≥ 220 mg/dL) | Normal: | 0.00 | 0.05 | 0.08 | 0.18 | 1.30 | 1.84 |
< 130/< 80 | (0.00–0.00) | (0.00–0.16) | (0.00–0.20) | (0.01–0.34) | (0.43–2.01) | (0.67–2.78) | |
High BP: | 0.00 | 0.00 | 0.08 | 0.36 | 1.60 | 2.62 | |
130–139/80–89 | (0.00–0.00) | (0.00–0.00) | (0.00–0.18) | (0.14–0.57) | (0.87–2.24) | (1.42–3.60) | |
G1 hypertension: | 0.00 | 0.00 | 0.00 | 0.46 | 1.51 | 2.79 | |
140–159/90–99 | (0.00–0.00) | (0.00–0.00) | (0.00–0.00) | (0.20–0.70) | (0.88–2.04) | (1.70–3.64) | |
G2–3 hypertension: | 0.00 | 0.00 | 0.58 | 1.34 | 3.73 | 5.77 | |
≥ 160/≥ 100 | (0.00–0.00) | (0.00–0.00) | (0.00–1.16) | (0.57–2.07) | (2.4–4.85) | (3.83–7.25) |
A total of 60,671 Japanese individuals from 13 cohorts were included and the total number of observations was 917,246 person-years, considering the mean follow-up period of 15 years. Intermediate-term risks were defined as mortality-adjusted cumulative rates for 10-, 20-, 30-, 40-, and 50-year risk of CHD death. CHD, coronary heart disease; DBP, diastolic blood pressure; SBP, systolic blood pressure; LTR, lifetime risk; TC, total cholesterol.